Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
Nürnberger Beteiligungs (NBG) delivered double-digit earnings growth in FY20, supported by slightly higher gross premiums booked, driven by new business as well as improved investment income in its traditional insurance segment. While management guidance assumes a slight decline in net income in 2021, the company is again optimistic about growth in new premiums across all segments this year. Management has proposed a dividend of €3.30/share (unchanged y-o-y), which implies a yield of 4.3%.
Nürnberger Beteiligungs |
FY20 earnings up despite low interest rates
Insurance |
Scale research report - Update
30 March 2021 |
Share price graph
Share details
Business description
Bull
Bear
Analyst
|
||||||||||||||||||||||||||
Nürnberger Beteiligungs (NBG) delivered double-digit earnings growth in FY20, supported by slightly higher gross premiums booked, driven by new business as well as improved investment income in its traditional insurance segment. While management guidance assumes a slight decline in net income in 2021, the company is again optimistic about growth in new premiums across all segments this year. Management has proposed a dividend of €3.30/share (unchanged y-o-y), which implies a yield of 4.3%.
FY20 earnings in line with management guidance
Management comfortably delivered full-year guidance for a y-o-y increase in net income (up 14.7% y-o-y to €77.4m in FY20). NBG’s gross premiums booked rose 2.2% y-o-y to €3.59bn, compared with 1.2% growth for the wider German insurance market in the period, based on estimates from the German Insurance Association (GDV). After a slight decline in new premiums in H120, NBG’s new business gained momentum in H220, reaching €629.4m in FY20, up 6.2% y-o-y. Low interest rates continue to weigh down NBG’s results, as reflected in higher additions to reserves, with Zinszusatzreserve (ZZR) up €219.8m versus €145.9m in FY19. While the net profit of its largest life insurance segment (c 70% of gross premiums in FY20) at €37.2m was higher than management’s forecast (€31m), net profit in Property & Casualty (P&C) fell more than expected, affected by a higher combined ratio of 94.9% in FY20 versus 91.0% in FY19.
Management guides to slightly lower profit in FY21
Management guides to a slight decline in net income in FY21, which it expects will largely be affected by additions to the equalisation reserve in the P&C segment given the overall low level of claims in FY20. That said, NBG expects good momentum in gross and new premiums in the health insurance and P&C segments. The largest life insurance segment should deliver stable profits amid higher new premiums and stable gross premiums, coupled with lower net investment income and a continued increase in ZZR, according to management.
Valuation: Offering a 4.3% dividend yield in FY21
NBG’s FY20 P/E of 11.4x represents a 14.3% discount to peers. Management has proposed a dividend of €3.30 per share based on FY20 earnings, which implies a yield of 4.3%, slightly lower than the median 5.1% for its peers.
|
Historical financials
Source: NBG accounts, Refinitiv |
Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.
Management expects slightly lower profit in FY21
GDV expects that gross premiums in the German insurance market will rise 2% y-o-y in 2021, with life insurance up 2% y-o-y, P&C up 1.5% y-o-y and health insurance up 5% y-o-y. Growth in life insurance should be assisted by including some catch-up effects from 2020, for example in pension products. P&C insurance may be negatively affected by the impact of reduced mobility on car insurance, as well as uncertainty among industrial companies, while GDV expects positive effects from private property insurance.
At group level, management expects stable gross premiums booked in FY21, assisted by significant growth in new premiums. That said, NBG guides to a slight decline in net income in FY21, largely due to higher additions to the equalisation reserve in the P&C segment. The latter will reduce the P&C insurance segment’s net profit to c €14m (vs €18.6m in FY20) despite higher gross premiums booked and new premiums in this segment, as expected by the management.
In the life insurance segment, management guides to significantly higher new premiums and stable gross premiums booked in FY21, as well as an unchanged segment result, mostly because of a reduction in net investment income and a continued increase in ZZR. Management acknowledges that net investment income in FY20 was achieved in favourable capital market conditions and is not assuming that the capital market environment in FY21 will be similarly supportive. At the same time, net investment income will be negatively affected by low interest rates, according to management. NBG’s strategic focus in this segment is on 1) income protection products in response to the persistent low interest rate environment; 2) the unit-linked offering in the private pension segment; and 3) ongoing digitalisation of the IT infrastructure, which should help the company transform from a ‘risk taker’ to a ‘health partner’ for its clients.
In the health insurance segment, both gross premiums booked and new premiums should grow significantly, with the latter continuing to be driven by supplementary and corporate health insurance products, according to management. NBG expects net profit in this segment will rise to c €7m in FY21 from €6.2 in FY20. Finally, management forecasts that the banking segment will achieve a similar profit to FY20 as better results in its asset management business and a slight growth in fee and commission income are unlikely to compensate for lower interest income in the period.
Valuation
NBG’s shares are trading at a FY20 P/E ratio of 11.4x, which represents a 14.3% discount to its peer group median, while its FY21e P/E ratio of 11.5x is 13.3% above the peer group average. However, we note that Refinitiv consensus on NBG are based on the estimates of one analyst, which was last updated in September 2020. Management has proposed a dividend of €3.30/share for FY20 (unchanged y-o-y), which implies a 4.3% yield compared with a 5.1% median yield for its peers.
Exhibit 2: Peer group comparison
Market cap |
Share price |
P/E (x) |
Dividend yield (%) |
|||
2020 |
2021e |
2020 |
2021e |
|||
UNIQA Insurance Group |
€2,002 |
6.46 |
57.7 |
8.8 |
2.8 |
6.3 |
Helvetia Holding |
CHF5,928 |
111.80 |
23.8 |
12.0 |
4.5 |
4.7 |
Baloise Holding |
CHF7,891 |
161.70 |
16.0 |
12.1 |
4.1 |
4.3 |
Ageas |
€9,853 |
50.50 |
8.5 |
10.5 |
5.3 |
5.4 |
Swiss Life Holding |
CHF14,917 |
465.90 |
13.7 |
11.8 |
4.4 |
4.9 |
NN Group |
€13,667 |
41.26 |
10.9 |
9.3 |
6.4 |
5.9 |
CNP Assurances |
€11,149 |
16.19 |
8.6 |
8.0 |
6.4 |
6.0 |
AXA |
€54,948 |
22.66 |
12.5 |
8.3 |
6.2 |
6.7 |
Allianz |
€88,735 |
214.60 |
13.2 |
10.7 |
4.5 |
4.8 |
Talanx |
€9,151 |
36.20 |
13.3 |
9.8 |
4.2 |
4.4 |
Peer group median |
|
|
13.3 |
10.1 |
4.5 |
5.1 |
Nürnberger Beteiligungs |
€879 |
76.50 |
11.4 |
11.5 |
4.3 |
4.3 |
Premium/(discount) |
|
|
(14.3%) |
13.3% |
(3.9%) |
(15.7%) |
Source: Refinitiv. Note: Priced at 29 March 2021. Note: Refinitiv consensus for Nürnberger Beteiligungs is based on the estimates of one analyst.
|
||||||||||||
Research: Industrials
Quadrise successfully completed a pilot trial at a customer site in Morocco during calendar H220 and launched its biofuel variant, bioMSAR which produces 20–30% lower carbon dioxide (CO2) emissions as well as lower nitrogen oxide and particulates. The company is currently preparing for larger scale trials in Morocco, a pilot trial in Utah and on-vessel trials with MSC Shipmanagement, having signed a joint development agreement with the shipping company this January. Management notes that these activities could potentially result in the first commercial shipments of MSAR by the end of calendar year (CY) 2021.